Head-to-head · WeighScore
Gala Health vs Marek Health
The verdict
Gala Health takes it — 82.9/100 to 66.9/100.
Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A compounded tirzepatide and semaglutide program for women that reaches all 50 states and keeps a brand-name Ozempic path open — but its $179 and $149 headline rates are yearly-subscription prices, not monthly ones.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Gala Health | Marek Health |
|---|---|---|
| WeighScore | 82.9/100 | 66.9/100 |
| Grade | B− | C |
| Scorecard rank | #17 | #173 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | $179/mo (yearly subscription) | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #17 · B−
Strengths
- Low compounded entry if you prepay the year — $179/mo tirzepatide and $149/mo microdose on the yearly subscription, $199/mo on a 3-month plan
- Prices are published openly rather than quiz-gated, with all doses included at the one rate
- All 50 states and LegitScript-verified, with a brand-name Ozempic path kept open ($1,299)
- HRT and menopause care available alongside GLP-1
Where it loses points
- No month-to-month price is published anywhere — the $179 tirzepatide and $149 microdose rates are both yearly subscriptions, and the shortest term Gala names is a 3-month plan at $199/mo
- Compounded formulations are not FDA-approved
- Brand-name Ozempic is priced steeply at $1,299
- No oral or sublingual route offered yet — injection only
- Newer operator (Gala GLP-1 by AI Coaching Inc) with no named clinicians and no named dispensing pharmacy
Graded #173 · C
Strengths
- Lab panels are core: initial comprehensive labs + 6–12 week follow-up + ongoing every 6 months — rare among GLP-1 providers
- Dedicated Health Coach paired with each client alongside partnered licensed physician as standard Proactive Care Team
- All 50 US states served; 100% telehealth with routine physician check-ins every 6 months built into the program
- Human optimization framing attracts pragmatic patients; partnered physicians selected for data-driven, high-leverage mindset
- No set subscription plan — custom protocol built around client health goals with option to cancel anytime
Where it loses points
- Pricing fully gated — no published rates; intake assessment required before quotes, limiting upfront comparison shopping
- Annual in-person physical required from own PCP or urgent care (every 12 months) — not provided by Marek Health
- No LegitScript certification found; platform explicitly disclaims being a healthcare clinic, which reduces regulatory trust signals
- Weight loss is one of many services alongside TRT, hair, brain focus, sexual health — not a dedicated GLP-1 platform
- Compounded vs. brand medication details not disclosed publicly — medication type determined post-intake with partnered physician
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.